|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-4-12
|
|
pubmed:abstractText |
A series of beta-carboxamido-phosphon(in)ic acids (2) was identified as a new structural motif for obtaining potent inhibitors of human mast cell chymase. For example, 1-naphthyl derivative 5f had an IC50 value of 29 nM and (E)-styryl derivative 6g had an IC50 value of 3.5 nM. An X-ray structure for 5f.chymase revealed key interactions within the enzyme active site. Compound 5f was selective for inhibiting chymase versus eight serine proteases. Compound 6h was orally bioavailable in rats (F=39%), and orally efficacious in a hamster model of inflammation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amides,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/CTSG protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cathepsin G,
http://linkedlifedata.com/resource/pubmed/chemical/Cathepsins,
http://linkedlifedata.com/resource/pubmed/chemical/Chymases,
http://linkedlifedata.com/resource/pubmed/chemical/Ctsg protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/Naphthalenes,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphinic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Serine Endopeptidases
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-2623
|
|
pubmed:author |
pubmed-author:AlmondHarold RHRJr,
pubmed-author:CantwellAngelene MAM,
pubmed-author:CorcoranThomas WTW,
pubmed-author:DamianoBruce PBP,
pubmed-author:Di CeraEnricoE,
pubmed-author:GrecoMichael NMN,
pubmed-author:HallJeffreyJ,
pubmed-author:HawkinsMichael JMJ,
pubmed-author:MaryanoffBruce EBE,
pubmed-author:MinorLisa KLK,
pubmed-author:PowellEugene TET,
pubmed-author:SavvidesSavvas NSN,
pubmed-author:WangYuanpingY,
pubmed-author:de GaravillaLawrenceL
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
19
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1727-30
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17361995-Administration, Oral,
pubmed-meshheading:17361995-Amides,
pubmed-meshheading:17361995-Animals,
pubmed-meshheading:17361995-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:17361995-Binding Sites,
pubmed-meshheading:17361995-Biological Availability,
pubmed-meshheading:17361995-Cathepsin G,
pubmed-meshheading:17361995-Cathepsins,
pubmed-meshheading:17361995-Chymases,
pubmed-meshheading:17361995-Cricetinae,
pubmed-meshheading:17361995-Crystallography, X-Ray,
pubmed-meshheading:17361995-Humans,
pubmed-meshheading:17361995-Mast Cells,
pubmed-meshheading:17361995-Models, Molecular,
pubmed-meshheading:17361995-Naphthalenes,
pubmed-meshheading:17361995-Phosphinic Acids,
pubmed-meshheading:17361995-Phosphonic Acids,
pubmed-meshheading:17361995-Rats,
pubmed-meshheading:17361995-Serine Endopeptidases,
pubmed-meshheading:17361995-Stereoisomerism,
pubmed-meshheading:17361995-Structure-Activity Relationship
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase.
|
|
pubmed:affiliation |
Research and Early Development, Johnson & Johnson Pharmaceutical Research and Development, Spring House, Pennsylvania 19477-0776, USA. mgreco@prdus.jnj.com
|
|
pubmed:publicationType |
Journal Article
|
